Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.

Nine patients with progressive, metastatic disease from primary carcinoma of the colon were entered into a phase I/II study using continuous intravenous infusions of granulocyte-macrophage colony-stimulating factor (GM-CSF) and high dose melphalan (120 mg m-2). GM-CSF was given alone to six patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Steward, W. P., Scarffe, J. H., Dirix, L. Y., Chang, J., Radford, J. A., Bonnem, E., Crowther, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971606/
https://www.ncbi.nlm.nih.gov/pubmed/1692472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971606/
https://www.ncbi.nlm.nih.gov/pubmed/1692472

Ejemplares similares